<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11547">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01844206</url>
  </required_header>
  <id_info>
    <org_study_id>AAAL3857</org_study_id>
    <nct_id>NCT01844206</nct_id>
  </id_info>
  <brief_title>Two Dose Epidural Morphine for Post-cesarean Analgesia</brief_title>
  <official_title>Two Dose Epidural Morphine for Post-cesarean Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to assess the analgesic effect of a two-dose epidural morphine regimen
      for 2nd day post-cesarean pain, as part of a multimodal analgesia regimen, which includes
      scheduled Nonsteroidal anti-inflammatory drugs (NSAIDs). The investigators hypothesize that
      administration of a second dose of epidural morphine 3 mg, 24 hours after an initial
      intraoperative dose, will provide superior post-cesarean analgesia during the 2nd 24 hours
      after surgery, compared to a single epidural morphine dose regimen. The primary outcome will
      be the amount of intravenous morphine patients self-administer during the 2nd 24 hours
      post-surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a randomized, double-blinded placebo-controlled study. In this study, women who
      underwent cesarean section with epidural anesthesia will receive 3 mg of epidural morphine
      intraoperatively, and have the epidural catheter left in place. Patients will be randomized
      to receive either epidural saline or epidural morphine 3 mg at 18 - 24 hours after the first
      dose of epidural morphine, following which the epidural catheter will be removed. It is
      standard of care at our institution for women undergoing cesarean section with epidural
      anesthesia to receive epidural morphine 3 mg. What is not typically carried out is to give a
      second dose of epidural morphine 3mg.

      The randomization will be carried out by a computerized block randomization table; the
      proportion for the 2 groups will be 1:1. The primary outcome will be the amount of
      intravenous morphine patients self-administer in the second 24 hours after surgery.
      Secondary outcomes will include pain scores every 6 hours, satisfaction with analgesia, side
      effects (itching, nausea/vomiting).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The amount of intravenous morphine patients self-administer in the 2nd 24 hours post-surgery.</measure>
    <time_frame>Up to 48 hours post-operatively</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Quality of Post-cesarean Analgesia During the 2nd 24 Hours After Surgery</condition>
  <arm_group>
    <arm_group_label>Epidural Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group receiving 3mg epidural morphine, 24 hours after the initial dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group receiving epidural saline 6ml, 24 hours after receiving epidural morphine 3mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural Morphine</intervention_name>
    <description>Patients will be given 3mg epidural morphine, 24 hours after the initial dose.</description>
    <arm_group_label>Epidural Morphine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural Saline</intervention_name>
    <description>Patients will be given epidural saline 6ml, 24 hours after receiving epidural morphine 3 mg.</description>
    <arm_group_label>Epidural Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Women undergoing cesarean section under epidural anesthesia.

        Exclusion Criteria:

          -  Emergent cesarean section

          -  Coagulopathy

          -  Failed epidural anesthesia or patchy block

          -  General anesthesia

          -  Use of epidural chloroprocaine

          -  Allergy or contraindication to Non-steroidal anti-inflammatory drug (NSAIDs)

          -  Severe opioid side effects

          -  History of chronic opioid use

          -  History of chronic pain

          -  History of obstructive sleep apnea

          -  Morbid obesity (Body Mass Index (BMI)&gt;45 kg/m2)

          -  Height under 4' 10&quot; (147 cm)

          -  Documented dural puncture by the epidural (Tuohy) needle

          -  Preeclampsia

          -  Other significant medical disease (American Society of Anesthesiologists (ASA) 3 or
             more).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Allison Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Allison Lee, MD</last_name>
    <phone>(305) 582-6077</phone>
    <email>al3196@columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Richard Smiley, MD</last_name>
    <phone>(914) 584-9531</phone>
    <email>rms7@columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Lee, MD</last_name>
      <email>al3196@columbia.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Zakowski MI, Ramanathan S, Turndorf H. A two-dose epidural morphine regimen in cesarean section patients: pharmacokinetic profile. Acta Anaesthesiol Scand. 1993 Aug;37(6):584-9.</citation>
    <PMID>8213024</PMID>
  </reference>
  <reference>
    <citation>Palmer CM, Nogami WM, Van Maren G, Alves DM. Postcesarean epidural morphine: a dose-response study. Anesth Analg. 2000 Apr;90(4):887-91.</citation>
    <PMID>10735794</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 4, 2013</lastchanged_date>
  <firstreceived_date>April 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Allison Lee</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
